Objective: To observe the clinical effects of xerophthalmia of meibomian gland dysfunction treated with tobradex combined with new tears ran. Method: 100 patients with xerophthalmia of meibomian gland dysfunction were selected and divided into 2 comparable groups randomly. The control group( n = 47 ) were treated with TBS after the conventional treatment. The observation group were treated with tobradex combined with hydroxyl glycoside eye drops after the conventional treatment. Comparing the BUT and ST on two groups of patients before and after treatment, and censusing the curative effects of 2 groups. Result: After treatment, BUT time of the patients of 2 groups postponed, the ST secretion increased, and the improvement of the observation group was more significant. The total efficiency of the observation group was 96. 23% , which was higher significantly than the control group for 89. 36% . The difference of the comparison a-bove was evident, which had statistical significance(p<0. 05 ). Conclusion: The treatment method of tobradex combined with hydroxyl glycoside eye drops to treat the patients with xerophthalmia of meibomian gland dysfunction is a kind of simple and effective curative method, which can be promoted as the conventional way in the clinical.%目的:探讨典必殊与新泪然联合应用治疗睑板腺功能障碍性干眼症的临床效果.方法:选取睑板腺功能障碍性干眼症患者100例,随机分为两组并使其有可比性.对照组(n=47)给予常规处理后使用托百士进行治疗;观察组(n=53)给予常规处理后使用典必殊联合新泪然进行治疗.对两组患者治疗前后BUT、ST进行比较,统计两组患者治疗效果.结果:两组患者经过治疗BUT时间延长,ST分泌量增加,且观察组改善更为明显;观察组患者总有效率为96.23%,明显高于对照组89.36%的比例.上述比较差异明显,有统计学意义(P＜0.05).结论:对睑板腺功能障碍性干眼症患者实施典必殊联合新泪然进行治疗是一种简便而有效的治疗方式,可以在临床中作为常规方式进行推广.
展开▼
